A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 71, Issue 4, 2012, Pages 511-517

  Rygg, Marite ^a,b   Pistorio, Angela ^c   Ravelli, Angelo ^d   Maghnie, Mohamad ^d   Iorgi, Natascia Di ^d   Bader Meunier, Brigitte ^e   Da Silva, Carlos ^f   Roldan Molina, Rosa ^g   Barash, Judith ^h   Dracou, Cristina ⁱ   Laloum, Sylvie Gandon ^j   Jarosova, Katerina ^k   Deslandre, Chantal Job ^l   Koné Paut, Isabelle ^m   Garofalo, Franco ⁿ   Press, Joseph ^o   Sengler, Claudia ^p   Tauber, Tsivia ^q   Martini, Alberto ^d   Ruperto, Nicolino ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^g HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^h KAPLAN MEDICAL CENTER   (Israel)

ⁱ AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^j CAEN UNIVERSITY HOSPITAL   (France)

^k INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^l Revmatologicky Ustav ^*  (France)

^m Section of Radiology   (France)

ⁿ OSPEDALE DEGLI INFERMI   (Italy)

^o BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^p CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^q ASSAF HAROFEH MEDICAL CENTER   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED PUBERTY; FEMALE; FOLLOW UP; GROWTH DISORDER; HEALTH CARE ORGANIZATION; HEIGHT; HUMAN; JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENARCHE; ONSET AGE; OUTCOME ASSESSMENT; PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANIZATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; AGE OF ONSET; ANTHROPOMETRY; BODY HEIGHT; BODY MASS INDEX; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; GROWTH; GROWTH DISORDERS; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PROSPECTIVE STUDIES; PUBERTY; PUBERTY, DELAYED; SEX FACTORS;

EID: 84857912567     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200106     Document Type: Article

References (40)

1. Cassidy JT, Petty RE, Laxer RM, et al. Systemic lupus erythematosus (chapter 21) In: Textbook OF pediatric rheumatology. Sixth edition. Philadelphia, Pa: Saunders Elsevier 2010:315-43.
2. Tucker LB, Menon S, Schaller JG, et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-72.
3. Brunner HI, Gladman DD, Ibañez D, et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008;58:556-62. (Pubitemid 351294890)
4. Hersh AO, von Scheven E, Yazdany J, et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum 2009;61:13-20.
5. Hersh AO, Trupin L, Yazdany J, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010;62:1152-9.
6. Hiraki LT, Hamilton J, Silverman ED. Measuring permanent damage in pediatric systemic lupus erythematosus. Lupus 2007;16:657-62. (Pubitemid 47360004)
7. Gutiérrez-Suárez R, Ruperto N, Gastaldi R, et al. A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2006;54:2989-96. (Pubitemid 44497780)
8. Ruperto N, Ravelli A, Murray KJ, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452-9. (Pubitemid 37508918)
9. Ravelli A, Ruperto N, Martini A. Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol 2005;17:568-73. (Pubitemid 41527817)
10. Lilleby V, Lien G, Frey Frøslie K, et al. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum 2005;52:2051-9. (Pubitemid 40994329)
11. Silva CA, Hilário MO, Febrônio MV, et al. Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study. Lupus 2007;16:531-6. (Pubitemid 47242530)
12. Brunner HI, Bishnoi A, Barron AC, et al. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus 2006;15:198-206.
13. Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004;16:566-70. (Pubitemid 39128326)
14. Ruperto N, Ravelli A, Oliveira S, et al. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement. Arthritis Rheum 2006;55:355-63. (Pubitemid 43887020)
15. Ruperto N, Ravelli A, Cuttica R, et al. The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set. Arthritis Rheum 2005;52:2854-64. (Pubitemid 41369116)
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
17. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
18. Cole TJ. Extreme percentiles of the 2000 Centers for Disease Control and Prevention BMI chart and the LMS method. Am J Clin Nutr 2010;91:814; author reply 815-16.
19. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992; 11:1305-19.
20. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990;44:45-60. (Pubitemid 20177198)
21. WHO Multicentre Growth Reference Study Group. WHO child growth standards: growth velocity based on weight, length and head circumference. Methods and development. Geneva, Switzerland: World Health Organisation (WHO), 2009:1-262.
22. de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660-7. (Pubitemid 47416716)
23. Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child 1970;45:755-62.
24. Goldstein H, Tanner JM. Child growth standards. Lancet 1980;2:35.
25. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 2000;85:3990-3.
26. Grote FK, Oostdijk W, De Muinck Keizer-Schrama SM, et al. The diagnostic work up of growth failure in secondary health care; an evaluation of consensus guidelines. BMC Pediatr 2008;8:21.
27. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
28. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
29. Styne DM, Grumbach MM. Puberty: ontogeny, neuroendocrinology, physiology, and disorders In: Kronenberg HM, Shlomo M, Polonsky KS, Larsen PR, eds. Williams textbook of endocrinology. 11th edition. Philadelphia, Pa: Saunders Elsevier 2008:969-1106.
30. Hughes IA, Kumanan M. A wider perspective on puberty. Mol Cell Endocrinol 2006;254-255:1-7. (Pubitemid 44041750)
31. Ravelli A, Duarte-Salazar C, Buratti S, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003;49:501-7. (Pubitemid 36988304)
32. Brunner HI, Silverman ED, To T, et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002;46:436-44. (Pubitemid 34136581)
33. Tucker LB, Uribe AG, Fernández M, et al. A dolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008;17:314-22. (Pubitemid 351655799)
34. Pluchinotta FR, Schiavo B, Vittadello F, et al. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus 2007;16:550-5. (Pubitemid 47359987)
35. Al-Mayouf SM, Al Sonbul A. Influence of gender and age of onset on the outcome in children with systemic lupus erythematosus. Clin Rheumatol 2008;27:1159-62.
36. Descloux E, Durieu I, Cochat P, et al. Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus. Rheumatology (Oxford) 2009;48:779-84.
37. B andeira M, Buratti S, Bartoli M, et al. Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus. Lupus 2006;15:515-20.
38. Haas JD, Campirano F. Interpopulation variation in height among children 7 to 18 years of age. Food Nutr Bull 2006;27 (4 Suppl Growth Standard) : S212-23.
39. Ong KK, Ahmed ML, Dunger DB. Lessons from large population studies on timing and tempo of puberty (secular trends and relation to body size): the European trend. Mol Cell Endocrinol 2006;254-255:8-12. (Pubitemid 44041754)
40. Medeiros PB, Febrônio MV, Bonfá E, et al. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 2009;18:38-43.